Penn State Hershey Medical Center

The trials here

What the 25 trials at this site are about, from their registry records.

Conditions

• Prostate cancer3 trials
• Acute lymphoblastic leukaemia2 trials
• Colorectal cancer2 trials
• Fatty liver disease (MASLD/MASH)2 trials
• Liver and biliary tract cancer2 trials
• Obesity2 trials
• Stroke2 trials
• Acute myeloid leukaemia1 trial
• Alzheimer disease1 trial
• Atrial fibrillation1 trial
• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial
• and 15 more

Phase

• Phase 39 trials
• Phase 24 trials
• Phase 43 trials

Status

• Completed7 trials
• Recruiting6 trials
• Active, not recruiting5 trials
• Terminated4 trials
• Not yet recruiting1 trial
• Suspended1 trial
• Withdrawn1 trial

Lead sponsor

• Milton S. Hershey Medical Center6 trials
• Novartis Pharmaceuticals2 trials
• Yale University2 trials
• Albany Medical College1 trial
• Ancora Heart, Inc.1 trial
• and 13 more

Running trials

• Recruiting

  Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  NCT07648264· Phase 3· CSL Behring· Source

  Contact: Trial Registration Coordinator

• Recruiting

  SSVC-CI During CABG

  NCT06645327· Milton S. Hershey Medical Center· Source

  Contact: Edward Stredny, MD

• Recruiting

  Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

  NCT06585410· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Active, not recruiting

  A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

  NCT06559163· Phase 2· Zenas BioPharma (USA), LLC· Source

• Active, not recruiting

  SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations

  NCT06239480· Phase 3· Palvella Therapeutics, Inc.· Source

• Recruiting

  Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

  NCT05629494· Phase 4· Albany Medical College· Source

  Contact: Jay Raman, MD

• Recruiting

  Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

  NCT05338697· Yale University· Source

  Contact: Raymond Reichwein, MD

• Active, not recruiting

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

  NCT05156281· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

  NCT04720157· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

  NCT04373564· Phase 4· Guerbet· Source

  Contact: Rebecca Jordan

• Recruiting

  Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  NCT03907046· Phase 3· Yale University· Source

  Contact: Nandakumar Nagaraja, MD

• Active, not recruiting

  A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

  NCT02954094· Target PharmaSolutions, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer2 recruiting
• Stroke2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Atrial fibrillation1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Liver and biliary tract cancer1 recruiting
• Melanoma1 recruiting
• Multiple myeloma1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Terminated

  Evaluation of Structural and Functional Integrity of the Rotator Cuff After Total Shoulder Arthroplasty

  NCT03921944· Milton S. Hershey Medical Center· Source

• Withdrawn

  Study of a Gene Therapy Treatment for Hemophilia A

  NCT06297486· Phase 3· Spark Therapeutics, Inc.· Source

• Completed

  Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

  NCT06195943· Milton S. Hershey Medical Center· Source

• Terminated

  Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment

  NCT04414514· Phase 2· Milton S. Hershey Medical Center· Source

• Completed

  NASH AMPK Exercise Dosing (AMPED) Trial

  NCT04987879· Milton S. Hershey Medical Center· Source

• Terminated

  Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia

  NCT05079230· Phase 3· Gilead Sciences· Source

• Completed

  CBT-I or Zolpidem/Trazodone for Insomnia

  NCT04468776· Phase 4· California Pacific Medical Center Research Institute· Source

• Terminated

  Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact

  NCT04731441· Milton S. Hershey Medical Center· Source

• Completed

  Comparing the Effects of Oral Contraceptive Pills Versus Metformin

  NCT03229057· Phase 3· Anuja Dokras· Source

• Completed

  Memory Improvement Through Nicotine Dosing (MIND) Study

  NCT02720445· Phase 2· University of Southern California· Source

• Completed

  A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

  NCT02723994· Phase 2· Incyte Corporation· Source

• Completed

  The Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) Study

  NCT01167270· Ian M. Paul, MD· Source